JP Patent

JP6633072B2 — ５−クロロ−ｎ４−［２−（ジメチルホスホリル）フェニル］−ｎ２−｛２−メトキシ−４−［４−（４−メチルピペラジン−１−イル）ピペリジン−１−イル］フェニル｝ピリミジン−２，４−ジアミンの結晶形態

Assigned to アリアド ファーマシューティカルズ，インコーポレーテッド · Expires 2020-01-22 · 6y expired

What this patent protects

Patent listed against Alunbrig.

Drugs covered by this patent

Patent Metadata

Patent number
JP6633072B2
Jurisdiction
JP
Classification
—
Expires
2020-01-22
Drug substance claim
No
Drug product claim
No
Assignee
アリアド ファーマシューティカルズ，インコーポレーテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.